ADCT
Price
$2.70
Change
-$0.15 (-5.26%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
267.92M
47 days until earnings call
QNCX
Price
$1.52
Change
-$0.08 (-5.00%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
78.21M
46 days until earnings call
Interact to see
Advertisement

ADCT vs QNCX

Header iconADCT vs QNCX Comparison
Open Charts ADCT vs QNCXBanner chart's image
ADC Therapeutics SA
Price$2.70
Change-$0.15 (-5.26%)
Volume$14.5K
Capitalization267.92M
Quince Therapeutics
Price$1.52
Change-$0.08 (-5.00%)
Volume$103
Capitalization78.21M
ADCT vs QNCX Comparison Chart in %
Loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADCT vs. QNCX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a Buy and QNCX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ADCT: $2.70 vs. QNCX: $1.50)
Brand notoriety: ADCT and QNCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 200% vs. QNCX: 51%
Market capitalization -- ADCT: $267.92M vs. QNCX: $78.21M
ADCT [@Biotechnology] is valued at $267.92M. QNCX’s [@Biotechnology] market capitalization is $78.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 0 FA rating(s) are green whileQNCX’s FA Score has 0 green FA rating(s).

  • ADCT’s FA Score: 0 green, 5 red.
  • QNCX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ADCT and QNCX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 5 TA indicator(s) are bullish while QNCX’s TA Score has 6 bullish TA indicator(s).

  • ADCT’s TA Score: 5 bullish, 4 bearish.
  • QNCX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, QNCX is a better buy in the short-term than ADCT.

Price Growth

ADCT (@Biotechnology) experienced а -10.89% price change this week, while QNCX (@Biotechnology) price change was +10.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

ADCT is expected to report earnings on Aug 12, 2025.

QNCX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADCT($268M) has a higher market cap than QNCX($78.2M). ADCT YTD gains are higher at: 35.678 vs. QNCX (-19.786). QNCX has higher annual earnings (EBITDA): -40.25M vs. ADCT (-95.64M). ADCT has more cash in the bank: 195M vs. QNCX (31.6M). QNCX has less debt than ADCT: QNCX (15.8M) vs ADCT (123M). ADCT has higher revenues than QNCX: ADCT (75.8M) vs QNCX (0).
ADCTQNCXADCT / QNCX
Capitalization268M78.2M343%
EBITDA-95.64M-40.25M238%
Gain YTD35.678-19.786-180%
P/E RatioN/AN/A-
Revenue75.8M0-
Total Cash195M31.6M617%
Total Debt123M15.8M778%
FUNDAMENTALS RATINGS
QNCX: Fundamental Ratings
QNCX
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADCTQNCX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 4 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 21 days ago
78%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGNCX13.020.25
+1.96%
Macquarie Natural Resources C
CSVFX21.24N/A
N/A
Columbia International Div Inc Inst
TREPX15.27N/A
N/A
Nuveen International Eq Premier
TQMIX18.10N/A
N/A
AMG TimesSquare Mid Cap Growth I
FERRX11.45N/A
N/A
First Eagle Global Real Assets R6

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with QTTB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
-2.17%
QTTB - ADCT
48%
Loosely correlated
-2.52%
VTYX - ADCT
44%
Loosely correlated
+2.08%
IMNM - ADCT
41%
Loosely correlated
+1.27%
OVID - ADCT
40%
Loosely correlated
+9.06%
CLRB - ADCT
40%
Loosely correlated
-7.05%
More